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The immune response by inbred strains of mice to the synthetic terpolymer L-glutamic 
acid6°-L-alanine3°-L-tyrosine  l°  (GAT)  1 is controlled by an H-2-1inked immune response 
( Ir) gene(s) (1, 2). Both responder ( H-2 a" b. ,~. ~') and nonresponder ( H-2 p' q, ") mice develop 
primary and secondary GAT-specific IgG plaque-forming cell (PFC) responses to GAT 
complexed to methylated bovine serum albumin (GAT-MBSA) in vivo and in vitro (3, 4). 
In responder, but not nonresponder,  mice GAT stimulates development of: (a) primary 
and secondary GAT-specific IgG PFC responses in vivo and in vitro (3); (b) radioresistant 
GAT-specific helper T cells (5); and (c) specific T-cell proliferative responses in cultures 
containing peritoneal exudate T  lymphocytes from immunized mice (6). Nevertheless, 
GAT  does  interact  with  the  immune  system of nonresponder  mice  causing  specific 
inhibition of the development of GAT-specific PFC responses to a subsequent injection of 
GAT-MBSA (7). This unresponsiveness is mediated by GAT-specific suppressor T cells 
(Ts) (8). 
The  mechanisms by which  these  and  other  Ts regulate  the  immune  response  are 
currently the subject of intense investigation. Although some Ts release soluble media- 
tors (9-11),  no suppressive activity has been detected in supernatant fluids of cultured 
GAT-specific Ts  (Kapp, unpublished  observations). However, a  suppressive factor has 
been extracted from thymus,  spleen,  and  lymph node  cells from GAT-primed nonre- 
spender  mice  (12). The  suppression  mediated  by  these  extracts  is  dose  dependent, 
demonstrable in vivo and in vitro, and specific for GAT (12). The active component in 
these extracts has a binding site(s) for GAT and an estimated mol wt of 45,000 (12). 
The correlation of:  (a) suppression by GAT; (b) GAT-induced Ts and;  (c) the 
suppressive activity of extracts from lymphoid cells of GAT-primed mice with 
genetic nonresponsiveness strongly suggests that the study of the soluble sup- 
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pressor substances  will result in further clarification of the mechanism(s)  by 
which Ir  genes  regulate  antibody  responses.  The  experiments  reported here 
establish the reproducibility of the in vitro assay for suppressive activity,  the 
time  aRer  GAT-priming  when  the  suppressive  factor  can  be  extracted,  the 
cellular source of suppressive  factor,  and the effect(s) of these factors on the 
immune  responses  of allogeneic  and  semisyngeneic  mice.  In  addition,  these 
experiments provide the foundation for the molecular characterization of this 
factor that will be described in subsequent papers. 
Materials and Methods 
Mice.  C57BL/6 (H-2~), DBA/1 (H-2q), SJL (H-2s), and A.SW (H-2") mice were purchased from 
The Jackson Laboratory, Bar Harbor, Maine. (C57BL/6 x  DBA/1)FI (H-2  blq) and (SJL × DBA/1)FI 
(//-2  "jq) mice  were  bred  in our animal  facilities.  Mice  were  used  at  2-8  mo of age  and  were 
maintained on laboratory chow and acidified-chlorinated water ad libitum. 
Antigens.  GAT,  tool wt 32,000,  was purchased from Miles Laboratories, Inc.,  Elkhart, Ind. 
MBSA, sheep red blood cells (SRBC),  GAT, and GAT-MBSA were prepared as described previ- 
ously (3). 
Preparation of Cell-Free Extracts.  Cell-free  extracts were prepared  as described previously 
(12).  Briefly, DBA/1 mice were injected i.p. with 10/~g GAT in Maalox (William H. Rorer, Inc., 
Fort  Washington,  Pa.)  or  with  Maalox  alone  (control).  Unless  otherwise  stated,  mice  were 
sacrificed 3 days later, and single cell suspensions of spleen and thymus were prepared and pooled, 
washed twice in Hanks' balanced salt solution,  and resuspended to 6  x  l0  s cells/ml in Eagle's 
minimum essential medium supplemented with 4 mM HEPES,  2 mM L-glutamine, and 50 U/ml 
each  penicillin and  streptomycin  (Microbiological Associates,  Bethesda,  Md.).  The  cells  were 
sonicated in a Sonifier Cell Disruptor, Model W-140-E (Heat Systems-Ultrasonics, Inc., Plainview, 
N. Y.) using a standard microtip. From 50 to 60 watts were delivered for 5 rain to 3-8-ml samples 
maintained at 7°C in a continous flow-cooling cell. The lysate was centrifuged at 40,000g at 4°C for 
1 h,  and the supernate was collected and stored at -80°C until use. 
Elimination  of Thymic Lymph Nodes.  Peri- and intra-thymic lymph nodes were labeled by 
injecting 0.2 ml India ink i.p.  into donor mice 24 h  before sacrifice (13).  The black lymph nodes 
were removed before preparation of single cell suspensions of thymus. 
Cell Separation Techniques.  Adherent cells (mostly macrophages) were depleted from suspen- 
sions of pooled thymus and spleen cells by serial passage over plastic Petri dishes as described 
previously (5).  The remaining nonadherent cells were fractionated into T-cell and B-cell popula- 
tions by passage over an immunoadsorbent column containing rabbit anti-mouse Ig coupled to 
Sephadex G-200 (8).  Briefly, nonadherent cells were resuspended at 20 x  106 cells/ml in Medium 
199 (Grand Island Biological Company,  Grand Island, N. Y.) containing 5% fetal calf serum, 2.5 
mM EDTA, and 50 U/ml each penicillin-streptomycin and applied in 10-ml vol to the immunoad- 
sorbent column containing 10 ml Sephadex  at 4°C.  The T  cells were eluted by addition of the 
EDTA-containing medium until the effluent was cell-free. The bound cells (B cells) were eluted 
with  medium  containing  10%  mouse  serum  as  a  source  of gamma  globulin.  This  method  of 
separation routinely yields T cells contaminated with only 0-7% Ig-bearing cells and B cells that 
are 85-96% Ig positive. 
Immunization  of Mice.  Mice were immunized i.p. with 10 ~tg GAT as GAT-MBSA in Maalox 
and pertussis vaccine (Eli Lilly Co., Indianapolis, Ind.). Extracts, 0.5 ml, were injected i.v. within 
2 h of antigen. 
Spleen Cell Cultures and PFC Assay.  Suspensions of single spleen cells containing 8  x  los 
nucleated cells/ml in completely supplemented culture medium were stimulated with antigen and 
incubated according  to  the  method  of Mishell  and  Dutton  (14)  with  modifications previously 
described  (15).  PFC  responses were assayed 7 days after in vivo immunization or 5 days after 
culture initiation using SRBC or GAT coupled to SRBC (GAT-SRBC) as indicator cells (3). 
Results 
Characterization of Suppressive Activity In Vitro.  We have previously dem- 
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were not cytoxic and did not suppress the in vitro responses by DBA/1 spleen 
cells to SRBC or GAT-MBSA at dilutions -> 1/200 (equivalent to 3 × 106 lymphoid 
cells/ml)  (12).  In fact,  dilutions  of control extracts  from 1/200  to  1/20,000  rou- 
tinely enhanced the PFC responses to both SRBC and GAT-MBSA by normal 
DBA/1 spleen cells (12). To standardize the in vitro assay of suppressive activity, 
extracts from GAT-primed DBA/1 mice were titrated on responses to SRBC and 
GAT-MBSA by normal DBA/1 spleen cells. The results of a  single representa- 
tive experiment (Fig. 1, panel A) demonstrate that an extract from GAT-primed 
DBA/1 mice inhibited the GAT-specific PFC response to GAT-MBSA, while the 
PFC response to SRBC was enhanced at all dilutions tested. To compare results 
of several  experiments,  the  data  have  been  standardized  by expressing  the 
suppressive activity of dilutions  of an extract as the percent inhibition  of the 
response to antigen developed by cultures containing no extract (Fig.  1, panel 
B). Since the response to SRBC is enhanced in culture containing these extracts, 
expression of these control data as percent inhibition yields negative numbers; 
therefore the SRBC controls were performed in each experiment,  but not plot- 
ted.  As  shown  in  Fig.  1,  panel  B,  repeated  titrations  of individual  extracts 
yielded remarkably  consistent data,  and  different batches of extracts  showed 
similar suppressive activity. In each experiment,  therefore,  the extracts were 
titrated,  the data plotted as percent inhibition,  and the 50% end points deter- 
mined.  The  suppressive  activity of each  extract can then be expressed in  S~o 
units as the inverse of the dilution giving 50% inhibition of the response (Fig. 1, 
panel C). If the 50% end point is not reached, but the data can be extrapolated, it 
is expressed as the  approximate  $5o units  (see no.  35,  panel  C).  If all  tested 
dilutions  of the extract give 100% inhibition,  the data are  expressed as ~  the 
last  dilution  tested  and  if no  dilution  tested  is  inhibitory  the  S~0  units  are 
expressed as <  the lowest dilution tested. 
Soluble Suppressive Component is Not Native GAT.  The original observa- 
tion that the GAT specifically inhibited the development of GAT-specific PFC 
responses to GAT-MBSA by nonresponder mice in vivo and in vitro (7) raises the 
possibility that the immunosuppressive material extracted from lymphoid cells 
of GAT-primed  nonresponder  mice  is,  in  fact,  native  GAT.  If all  the  GAT 
injected  into  the  donor  mice  were recovered in  the  spleen  and  thymus,  the 
concentration  of GAT would be 20-30  ~g/ml  of extract.  Therefore,  GAT was 
added to an extract prepared from lymphoid cells of control DBA/1 mice to give a 
GAT concentration  of 25  ~g/ml  (Table I, Groups C, D,  E,  F).  The suppressive 
activity  of these  GAT-containing  control  extracts  was  compared  to  that  of 
extracts  prepared  from  GAT-primed  DBA/1  mice  (Groups,  G,  H,  I).  The  re- 
sponses to GAT-MBSA in the absence of any factor (Group A) or in the presence 
of control extract (Group B) demonstrated the lack of effect of the control extract 
alone.  Significant suppression occurred only in mice that received 1:5 and 1:10 
dilutions of the extract from GAT-primed mice (Groups G and H). 
The effect of these three types of extracts on the responses to GAT-MBSA in 
DBA/1 spleen cell cultures  was also examined  (Fig.  2).  Only the  extract pre- 
pared  from  GAT-primed  DBA/1  mice  was  suppressive.  We  have  previously 
demonstrated that inhibition of the GAT-specific PFC responses to GAT-MBSA 
by nonresponder  mice requires injection of -> 1.0  ~g of GAT in Maalox i.p.  or J.  A.  KAPP,  C.  W.  PIERCE~  AND  B..  BENACERRAF  831 
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Fro.  1.  In vitro analysis of lymphoid cell extracts from GAT-primed DBA/1  mice. All 
extracts were prepared from pooled thymus and spleen cells (6 × 108 cells/ml) from DBA/1 
mice primed 3 days earlier with 10 ~g GAT in Maalox. The extracts were diluted and added 
to spleen cells from normal DBA/1 mice at culture initiation, IgG PFC responses to SRBC 
and GAT were assayed after 5 days. (panel  A)  Activity of a single extract on the IgG PFC 
response to SRBC (O--O) and GAT-MBSA (O--O). PFC responses in cultures containing 
no extracts are given to the left of the titration curves. (panel B) Suppressive activity of 
four separate extracts expressed as the percent inhibition of the response to GAT-MBSA in 
cultures  containing  no  extracts.  Number  of  experiments  performed  in  parentheses. 
(O---O) no.  28  (7); (A---A) no.  34  (3); (B--I) no.  35  (4); (O--O) no.  39  (10). (panel 
C)  Expression of inhibitory activity as the inverse of the dilution of extract causing 50% 
inhibition of the PFC response to GAT-MBSA S~ units/ml. 
>0.1  /~g GAT/ml of culture medium  (7). Therefore, we conclude that an insuffi- 
cient amount  of GAT is present in extracts from GAT-primed nonresponder mice 
to account for the specific suppression observed. 
Correlation  Between the Presence of Suppressor Cells (T,) and the Suppres- 
sive Activity in Lymphoid Cell Extracts.  Spleen cells from DBA/1 mice injected 
with 10 ~tg GAT in Maalox specifically suppress the immune  responses to GAT- 
MBSA by an equal number  of spleen cells from normal  DBA/1 mice in vitro (8). 
Ts activity can be detected from 3 to 21 days after the injection of GAT (Fig. 3). 
Similarly,  soluble  suppressive  factor  can  be  extracted  from  lymphoid  cells of 832  IMMUNOSUPPRESSIVE  FACTOR(S)  FROM  NONRESPONDER  MICE 
TABLE  I 
Suppressive  Component  in Extracts Is Not Native GA T 
0.5 ml extract 
Extract di-  Soluble  GAT-specific IgG  Suppres- 
Group*  from mice 
lution  GAT added  PFC/spleen§  sion 
primed with$ 
P 
p.g  arith, mean  +_ SE  % 
A  No extract  -  -  7,900  _+  900  -  - 
B  Maalox  1:5  -  7,400  _+  1,500  7  - 
C  Maalox  1:5  2.5  6,200  _+  500  21  0.4841 
D  Maalox  1:10  1.25  5,900  _  800  26  0.391 
E  Maalox  1:20  0.6  4,900  +_  1,000  38  0.205 
F  Maalox  1.120  0.1  5,000  +_ 500  37  0.321 
G  GAT  1:5  -  2,200  _+  1,200  72  0.022 
H  GAT  1:10  -  1,900  _+  1,100  76  0.014 
I  GAT  1:20  -  4,800  +_  1,200  39  0.219 
* Six mice per group. 
Extracts injected i.v. within 1 h  of injection of GAT-MBSA in Maalox-pertussis i.p. 
§ PFC response day 7. 
II P  value determined by Student's t  test comparing all experimental groups with Group B. 
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FIG.  2.  Suppressive  factor  in  extracts  of GAT-primed  DBA/1  mice  is  not native  OAT. 
Normal  DBA/1  spleen cells  (8  x  l0  s)  were  incubated with  various dilutions  of a  control 
extract  (©- -  -©),  a  control extract to which 25  ~g GAT was added to  1 ml of undiluted 
extract, (A--A) or an extract from GAT-primed mice (O--O). Extracts were added to spleen 
cells at culture  initiation  and IgG  PFC  responses to  SRBC  (not shown) and  GAT-MBSA 
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FIG.  3.  Comparison of suppressive activity of spleen cells (I--I)  vs.  lymphoid cell ex- 
tracts (O- -  -O) at various times after injection of 10  ~g GAT in Maalox.  Primed spleen 
cells (8 x  10  6) or dilutions of  the extract were added to normal DBA/1 spleen cells (8 x  10  6) at 
culture initiation, and the IgG PFC responses  to SRBC (not shown) and to GAT-MBSA were 
assayed after 5 days. 
DBA/1 mice from days 3 to 14 after injection of GAT (Fig. 3).  (Days between 14 
and 38 were not tested for suppressive extract.) 
Cellular  Source of Suppressive  Factors.  The correlation  between the pres- 
ence of Ts  and  the  suppressive  activity of extracts  prepared  from  spleen  and 
thymus cells of GAT-primed nonresponder  mice suggests that the suppressive 
factor is a T-cell product. To test this hypothesis more directly, two approaches 
were taken. 
The contribution of contaminating lymph node cells to the activity in thymus 
extracts was excluded by removing peri- and intrathymic  lymph nodes before 
preparation  of the  extracts.  DBA/1  mice  were  injected  with  10  /~g  GAT  in 
Maalox, 2 days later half of the mice were injected i.p. with 0.2 ml dialyzed India 
ink (13). All mice were sacrificed 1 day later, their thymuses removed, the black 
lymph nodes removed from the thymuses of mice that received India ink,  and 
extracts  prepared  and  titrated  as  usual.  The  suppressive  activity of extracts 
prepared from thymuses without lymph node cells was equivalent to the activity 
in thymuses prepared in the usual manner  (Table II). 
To identify the cellular source of the suppressive factor directly, spleen and 
thymus cells from GAT-primed DBA/1 mice were purified  in two steps.  First, 
adherent  cells were removed by passage over plastic dishes.  Second,  B  and T 
cells were prepared by passage of the nonadherent cells over columns containing 
rabbit  anti-mouse  Ig  bound  to  Sephadex  G-200  (8).  Extracts  prepared  from 
unseparated  cells,  nonadherent  cells,  B  cells,  and  T  cells  were  titrated  for 
suppressive activity in vitro  (Table III).  Specific suppressive  activity was de- 
tected in all extracts except that prepared from B cells. Dilutions of the extracts 
were  adjusted  to  an  equivalent  number  of cells  and  the  recovered  activity 
increased  in  this  order:  unseparated  lymphoid  cells  <  nonadherent  cells  <T 
cells. Therefore,  we conclude that the suppressive component in lymphoid cell 
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TABLE  II 
Thymic Lymph Node Cells Are Not the Source of Suppressive 
Factor 
$5o  units/ml* 
Extract from mice primed with GAT 
SRBC  GAT-MBSA 
Spleen  <200  650 
Thymus$  <200  1,200 
Thymus without lymph nodes§  <200  1,150 
* Sso  units/ml determined at day 5 as described in Fig. I. 
Extract prepared from thymuses of  GAT-primed DBA/1 mice. 
§ Extract prepared from thymuses of GAT-primed DBA/1 mice after 
removal of  peri-  and intra-thymic lymph nodes. 
TABLE III 
Suppressive Factor Is a T-Cell Product 
Extract prepared from 
lymphoid cells of GAT- 
primed mice* 
$5o  units/ml$ 
SRBC  GAT-MBSA 
Spleen +  thymus  <200  540 
Nonadherent cells  <200  750 
T cells  430  1,200 
B cells  <200  <200 
* Spleen and thymus cells from GAT-primed DBA/1 mice were pooled 
and sequentially fractionated into nonadherent cells,  T cells,  and B 
cells.  Extracts  were  prepared  from  each  of these  populations,  the 
dilutions were adjusted such that the undiluted extracts were equiva- 
lent to 6  × 108  cells/ml. 
$5o  units/ml determined at day 5 as described in Fig. 1. 
Suppressive Activity of DBA/1 Extract on Immune Responses by Semi-Synge- 
neic and AUogeneic Spleen Cells.  Dilutions  of an extract  from GAT-primed 
DBA/1 mice were added to cultures containing spleen cells from DBA/1  (H-2q), 
C57BL/6 (H-2~),  A.SW (H-2'),  (C57BL/6  ×  DBA/1)F,  (H-2blq), or (SJL  ×  DBA/ 
1)F1 (H-2 "~) mice. The results demonstrate that the DBA/1 extract can specifi- 
cally suppress responses of A.SW mice to GAT-MBSA across histocompatibility 
barriers  (Table IV).  However,  restrictims  were demonstrated in that suppres- 
sion of responses by allogeneic and semi-syngeneic spleen cells occurred only in 
spleen cells that were nonresponders to GAT, i.e.  (A.SW and (SJL × DBA/1)F1). 
Discussion 
The  immunosuppressive  activity  of extracts  from  lymphoid  cells  of GAT- 
primed nonresponder mice can be assessed in vivo and in vitro (12). Titration of 
several different extracts in many separate experiments has shown that the in 
vitro assay provides a reproducible, semi-quantitative measure of specific sup- 
pressive activity  (Fig.  1).  This  assay required  only small  amounts  of extract 
which was essential for the molecular characterization of the suppressive moiety 
described in the accompanying paper (16). 
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TABLE IV 
Effect of DBA/1 Extract on PFC Responses by Allogeneic and Semi-Syngeneic Mice 
In Vitro 
Strain*  H-2  Response to GAT 
$5o units/ml$ 
SRBC  GAT-MBSA 
DBA/1  q  -  <400  >1,600 
C57BL/6  b  +  <400  400 
(C57BL/6  ×  DBA/1)F1  b/q  +  <400  <400 
A.SW  s  -  <400  1,500 
(SJL  ×  DBA/1)F1  s/q  -  <400  1,600 
* Dilutions of an extract from GAT-primed DBA/1 mice were added to 107 spleen cells from various 
strains of mice at culture initiation. 
$ S~o units/ml determined at day 5 as described in Fig.  1. 
cluding helper T-cell-replacing  factors  (17,  18) and suppressor factors  (19,  20). 
These  molecules  share  certain  properties:  mol  wt  of approximately  50,000, 
antigen-binding sites, the lack of Ig determinants,  and the presence of determi- 
nants recognized by alloantisera  specific for I-region gene products.  It seemed 
likely that  the  factor  identified  in  lymphoid  cell  extracts  from  GAT-primed 
nonresponder  mice  belonged to  this  new group  of mediators.  However, since 
native GAT and the suppressive factor have similar, specific suppressive activi- 
ties as well as mol wt of 30,000-50,000,  it was necessary to determine whether 
the suppressive factor in these lymphoid cell extracts was native GAT. 
If all the GAT injected into the donor mice were recovered in the spleen and 
thymus, an unlikely possibility, the maximum concentration of GAT would be 
20-30  #cg/ml  of extract.  Therefore,  this  concentration  of GAT was added to a 
control extract and its suppressive activity determined.  No significant suppres- 
sion was mediated by control extract or the control extract containing GAT at 
dilutions  that  extracts from GAT-primed  mice were suppressive  (Table I  and 
Fig.  2).  Inasmuch  as the  minimum  amount  of GAT required  to suppress  the 
response to GAT-MBSA was previously shown to be -> 1.0/~g/mouse and  >0.1 
/~g/ml of culture medium (7), we conclude that the concentration of native GAT 
in extracts  from  GAT-primed  mice is insufficient to account for the observed 
suppression.  Furthermore,  data presented in the following paper  (16) confirm 
that this suppressive factor belongs to a  new class of antigen-specific immuno- 
regulatory factors. 
After injection of 10 fig GAT in Maalox, the presence of the suppressive factor 
in  thymus  and  spleen  cell  extracts  is  correlated  with  the  appearance  of Ts. 
Furthermore, soluble suppressive factor can be extracted from T cells, but not B 
cells,  of GAT-primed  nonresponder  mice.  Thus,  the  active  moiety  in  these 
extracts is a T-cell product. Experiments are currently in progress to confirm the 
hypothesis that the factor is a suppressor T-cell product. 
An extract prepared from GAT-primed DBA/1 mice specifically suppresses the 
immune response to GAT-MBSA by normal spleen cells from DBA/1, A.SW, and 
(SJL ×  DBA/1)F1 mice (Table IV). These data demonstrate that a  GAT-specific 
factor from DBA/1 mice can suppress antibody responses by H-2 histoincompati- 
ble cells, but that the suppression is restricted to strains that are nonresponders 836  IMMUNOSUPPRESSIVE  FACTOR(S)  FROM  NONRESPONDER  MICE 
to GAT. This contrasts to the observations of  Tada and Taniguchi (21) who found 
that a  KLH-specific factor can effectively suppress  antibody responses of H-2 
compatible strains, but not those of H-2 incompatible strains. However, we have 
previously reported that a factor obtained from GAT-primed A.SW mice failed to 
suppress the response to GAT-MBSA by nonresponder DBA/1 mice (22). These 
differential effects of extracts from mice of different nonresponder haplotypes 
may be of considerable significance; however, more studies are necessary to rule 
out trivial explanations such as differences in relative concentrations of  suppres- 
sive factors in each extract. Experiments are currently in progress to titrate the 
suppressive activity in extracts prepared from mice of all three nonresponder 
haplotypes  (H-2  p.q,s)  on  immune responses  by  spleen  cells  from  a  panel  of 
various  inbred  strains  of mice  in  vitro.  When  trivial  explanations  for  this 
observation  are  eliminated,  it  will be  of interest to  determine whether the 
ability to be suppressed by a given extract is genetically controlled. 
Summary 
The synthetic terpolymer of L-glutamic acidS°-L-alanine3°-L-tyrosine  ~° (GAT) 
fails to  stimulate development of GAT-specific antibody responses  in nonre- 
sponder strains of mice, but does stimulate the development of GAT-specific 
suppressor T  cells that inhibit the development of normal anti-GAT antibody 
responses  to  GAT  complexed  to  methylated bovine  serum  albumin  (GAT- 
MBSA).  Furthermore, extracts prepared from lymphoid cells of GAT-primed, 
but  not control,  nonresponder mice inhibit the  development of antibody re- 
sponses  to  GAT-MBSA  by  normal  nonresponder  mice.  This  suppression  is 
specific, dose-dependent, and can be readily analyzed in vitro. The suppressive 
factor is a T-cell product. An extract from GAT-primed DBA/1 mice inhibits the 
response to GAT-MBSA by spleen cells from histeincompatible strains of mice 
that are nonresponders to GAT, but not strains that are responders to GAT. 
The authors thank Cheryl Petrell for her enthusiastic and competent technical assistance and 
Sally Menkhus for her skillful preparation of this manuscript. 
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